Cancer vaccines have a brutal track record — decades of failures, billions wasted, and patients let down by treatments that triggered lab responses but couldn't help people live longer. The biology is genuinely hard: tumors cloak themselves, mutate around targeted antigens and suppress immune responses. Recent mRNA results are promising but still limited to specific settings, and manufacturing personalized vaccines at scale remains a massive unsolved problem.